Archive for September, 2010

Kreisler Manufacturing Corp. (KRSL.PK) Details Expansion Project and 3 Strategic Agreements

Thursday, September 30th, 2010

Kreisler Manufacturing Corp. manufactures precision metal components for military and aerospace use, commercial aircraft engines and industrial gas turbines. The company today announced its strategic capital investment project at its Kreisler Polska subsidiary designed to expand the company’s manufacturing and production capabilities in Poland.

After its estimated completion in December 2010, the Kreisler Polska expansion is expected to enhance competitiveness and generate long-term revenue growth. Kreisler said the project reflects its growing presence in Europe and its drive to meet rising customer demand.

“These actions are designed to enhance our competitive position as well as enable Kreisler to compete for expanded market share leading to revenue growth. Additionally, by extending and complementing capacity at Kreisler Polska we will be well positioned to meet growing demand internationally,” Kreisler CEO Michael Stern stated in the press release.

The project will include a new 60,000-square foot manufacturing facility in Niepołomice, Poland, that will enable the company to significantly ramp up its tube and manifold assembly capabilities. It will also increase production and machining capacity.

In accordance with its expansion efforts, Kreisler has also entered into a 10-year long-term agreement with two customers. Per the agreement, more than 1,000 part numbers, which are currently produced by these customers, will be produced at Kreisler Polska’s new facility.

Additionally, Kreisler inked an equipment purchase and sale agreement with a third customer to purchase certain manufacturing and assembly equipment necessary for Kreisler Polska to produce tube and manifold assemblies of multiple sizes and configurations.

“The capacity expansion and supporting long-term agreements enhances our ability to deliver the next generation of turbine engines and demonstrates our organizations strong commitment to our customers,” Ned Stern, Kreisler’s CFO stated. “The expansion is a significant business growth opportunity and we appreciate the support and assistance provided by the European Union and the Polish Enterprise Development Agency to make this project a reality. We look forward to a great partnership with this community for many years to come.”

The terms of the long-term agreement is expected to be completed by March 2012.

For more information visit

Let us hear your thoughts below:

Best Energy Services, Inc. (BEYS.OB) to Expand into Eagle Ford Shale

Thursday, September 30th, 2010

Best Energy Services, – the Houston, TX-based well service and workover firm providing leading solutions in the Hugoton and Central Kansas Basin, announced plans today to expand operations into the Eagle Ford trend of South Texas very soon, projecting a late November date to have multiple rigs up and running.

The Company has positioned itself superbly to capitalize on the Eagle Ford Shale over the next several years, and sees it as a primary growth area due to extremely promising initial results.

It is now estimated that the trend stretches out over most, if not all, of 15 different counties in south Texas, with production targets ranging from 4-12k ft – data which leads sector magnate EOG Resources to characterize the trend as “the sixth largest domestic oil discovery in U.S. history.”

Estimates for total reserves in the field exceed 900M barrels of recoverable oil, with conservative industry forecasts project over 30k barrels per day of oil and natural gas liquids, and 1B cubic feet of natural gas within just three years of development.

Other major industry players are already operating in the area, some of which are already customers of the Company in the Hugoton. Others, including EOG Anardako, Apache Corp., BP, Chesapeake Energy, ConocoPhillips, Exxon-XTO, Petrohawk, Pioneer, Swift Energy, Shell and Goodrich, are making serious plays.

Chairman and CEO of BEYS, Mark Harrington, noted how six months ago the Company identified this trend as being the preeminent source rock play for several years to come, back when there were only 20 drilling rigs in the area – a number which today stands at well over 50.

Harrington explained that a single drilling rig can generally support two or more workover rigs, and that the Company would employ the same strategies that have led to success in the Hugoton, where BEYS has obtained a “First Call” status among over half of the Basin’s operators.

Harrington detailed the tried-and-true methodologies of safety first, value pricing for the customer, and use of highly skilled crews, all of which are absolutely essential, and projected that the Company will have ten or more rigs servicing South Texas customers within the next year.

Harrington concluded by pointing to BEYS having doubled revenues over the last year and explained that successful execution of this project would be able to sustain that momentum through 2011.

Formal initiation of the launch of operations will be made at the Hart Energy Publications Eagle Ford Conference in San Antonio, where the Company is a sponsoring exhibitor, from October 4 through the 6 – a showcase which is anticipated to bring in several key potential E&P customers as well as over 2k attendees.

Let us hear your thoughts below:

Glen Rose Petroleum Corp. (GLRP.OB) Acquires 4,500 Acres Contiguous to Current Operations in Texas

Thursday, September 30th, 2010

Glen Rose Petroleum, – the 29-year veteran, on-shore US oil and gas developer, with some 10.5k acres in Edwards County, Texas’ Wardlaw Field (medium crude of 18-22 API gravity with a 2% sulfur content), today reported acquisition of another 5.4k acres at the Adamson Ranch, which is contiguous to the aforementioned acreage and brings the Company’s total footprint to roughly 15,900 acres.

With a 100% working interest and 20% royalty interest in the Adamson Ranch, GLRP is well-positioned to fully exploit the rich reserves at the site, where engineering study data indicates the presence of an estimated 168.7M barrels of oil-in-place (1984 study on the Wardlaw).

That same report showed that the vast majority of reserves are at a depth of approximately 300 ft., with the light-gravity, heavy oil resource trapped in the dolomitic upper Glen Rose “A” Zone.

COO of GLRP, Ruben Alba, discussed future plans for extensive development at the site by characterizing the acquisition as a shrewd move towards establishing a firm leasehold footprint. Alba also went over exploration data which indicates that the Adamson is “continuous in strata” to the current asset area.

Alba also mentioned the statistical breakdown of the reserves, which occur in multiple productive shallow oil horizons, and explained how the unique completion process and vast experience of the Company would be key to maximizing output as the current pilot matures towards the development of the site’s full potential.

Glen Rose Equity Partners, LLC holds a 12.5% working interest in the Wardlaw, with terms and conditions yielding the right to acquire up to 50% working interest in any additions acquired by GLRP external to the defined area of mutual interest, such as the Adamson.

President of GLRP, Andrew Taylor-Kimmins, spoke of the overall plan for the area and noted how this acquisition is in accordance with the Company’s strategy to acquire some 60k acres within the shallow oil fairway stretching across Edwards, Sutton and Val Verde Counties in Texas.

Taylor-Kimmins explained that the major rework of the Wardlaw, with 26 active producing wells, was proceeding apace of expectations and that the implementation of improved technologies as operations advance was a major element to the Company’s strategy to maximize shareholder returns while creating an extensive production infrastructure in the region.

Let us hear your thoughts below:

Huifeng Bio-Pharmaceutical Technology Inc. (HFGB.OB) is “One to Watch”

Thursday, September 30th, 2010

Huifeng Bio-Pharmaceutical Technology Inc., located in Xi’an, People’s Republic of China, is focused on developing, producing and selling plant extracts, pharmaceuticals and pharmaceutical raw materials in China and internationally. It is the leading Chinese producer of rutin and related plant-derived chemicals in a class called flavonoids, which have anti-inflammatory, antioxidant and anticoagulant properties.

Huifeng’s production facilities are ISO9001:2000 certified, a necessary international qualification for export sales. The company also holds a Chinese Good Manufacturing Practices (GMP) certification, which was just recently renewed by the SFDA for five years. Products manufactured under GMP conditions have higher quality, consistency and potency assurances.

With a market cap of only $14.94 million, the company trades at a P/E of 2.84 and P/S of 0.72. The company’s balance sheet is solid with $22.05 million in assets and $3.24 million in liabilities. Also of note, management holds a combined 34.51% of the shares outstanding.

Over the past three years, revenues have grown at an average annual rate of 64.77% while EPS (GAAP) has increased 167.70% on average. Huifeng’s book value has also rapidly increased, growing 27.30% per year. Following the recent acquisition of Shangqiu Kexin Rutin Processing Ltd., management expects growth to continue in the following quarters.

Let us hear your thoughts below:

XenaCare Holdings, Inc. (XCHO.OB) Partners With Renaissance Publishing

Thursday, September 30th, 2010

XenaCare Holdings, Inc., a Florida based healthcare products company, today announced signing of an agreement with Renaissance Publishing LLC, for the private label marketing of three XenaCare clinical supplement products. XenaCare will furnish the finished products to Renaissance for marketing in the U.S., with Renaissance providing the packaging and branding. Renaissance is a multimillion dollar company with 150,000 customers to which XenaCare now has access.

XenaCare President and CEO, Frank Rizzo, commented on the agreement. “We are very pleased to be working with Renaissance for U.S. private label marketing of these proprietary clinical supplement products. They fit into Renaissance’s growing portfolio of anti-aging dietary supplements that promote increased health, well-being, and life expectancy and allow us to concentrate our efforts and resources on Cobroxin(TM). We believe that the Renaissance strategy of providing education about its products along with its direct response sales model will result in greater awareness and sales of these unique products and look forward to a successful relationship with Renaissance.”

XenaCare engages in the formulation, marketing, and distribution of a wide range of healthcare products, including over-the-counter pain medication, cholesterol control and cardiovascular clinical products, as well as lifestyle performance products. The company markets its products through the Internet, pharmacies, doctors’ offices, plus food and drug stores.

The company recently received the exclusive license to market and distribute Zeolite, from Mineral Sciences, used for cellular detoxification. Research suggests Zeolite ingredients may help with viral infection and support healthy blood sugar levels. In addition, it improves nutrient absorption, supports immune system function, and reduces symptoms related to allergies. XenaCare was also awarded U.S. marketing rights to Cobroxin, the first over-the-counter pain reliever clinically proven to treat chronic pain. Cobroxin is an all-natural, non-addictive pain medication, said to be clinically proven to be more effective than morphine.

For more information, visit the company’s website at

Let us hear your thoughts below:

LeCroy Corp. (LCRY) Reports Preliminary First Quarter Results

Thursday, September 30th, 2010

LeCroy Corp. is a worldwide leader in serial data test solutions and oscilloscopes. The company offers high-performance oscilloscopes, serial data analyzers and global communications protocol test solutions which measure, analyze and verify complex electronic signals.

The company today announced preliminary financial results for its fiscal first quarter ending October 2, 2010. For the first quarter of fiscal 2011, LeCroy expects to report a 38% year-over-year increase in revenues to approximately $38.6 million. This compares with $28 million in the first quarter of 2010 and previous guidance of between $37 million and $38 million for this quarter.

LeCroy also expects to report year-over-year order growth of 50% for the first quarter of fiscal 2011. This reflects strong orders for oscilloscopes, which grew 56% from last year and 14% compared with the previous quarter. The company believes the upsurge in its orders is due to its introduction of new products over the past year.

The company expects to follow the same path to success by also announcing on September 29, 2010 the launch of five new products. The products include an updated version of its award-winning WaveMaster 8 Zi series oscilloscopes, a new 4-channel 20 gigahertz oscilloscope, and a range-topping oscilloscope with 45 gigahertz of real-time bandwidth – the WaveMaster 845 Zi-A.

In addition, LeCroy launched SPARQ, which helps customers directly solve many advanced signal integrity problems. Finally, it announced LabMaster, a new family of high-speed, multi-channel oscilloscope modules. For more information on LeCroy, please visit the company’s website at

Let us hear your thoughts below:

Clear Skies Solar, Inc. (CSKH.OB) Receives High Praise for XTRAX® Technology

Thursday, September 30th, 2010

Clear Skies Solar, Inc. may have blue skies in their future as indicated by today’s announcement about the success of their XTRAX Technology. Located in Mineola, New York, Clear Skies Solar (CSS) is a wholly-owned subsidiary that provides full-service renewable energy solutions to commercial, industrial, and agricultural clients across the country. Today, CSS took a major step towards prominence when they announced that independent lab testing proves high accuracy for their XTRAX Technology.

XTRAX is hardware that has the potential to lead the next generation of energy tracking. The first seven ANSI tests relating to accuracy and continuity have shown compliance with ANSI standards which could mean big things for CSS.

The US patent for XTRAX is held by Carbon 612, which is a majority-owned subsidiary of CSS. With CSS monitoring the progress of XTRAX, the hardware may become a global presence in the near future with patent applications pending in the Chinese and European markets.

CEO Ezra Green was quoted as saying, “The XTRAX hardware, firmware and our server-based software was developed in-house with plans on entering into several additional renewable-based markets. By expanding the Carbon 612 recurring-revenue model, we will be ensuring that our market positioning and growth will be well-rounded.”

To learn more about CSS, visit the company website at:

Let us hear your thoughts below:

Golden Star Resources (GSS) is “One to Watch”

Thursday, September 30th, 2010

Golden Star Resources is a mid-tier, unhedged gold mining company which over its 25-year history has produced in excess of 2 million ounces of gold. The company has two operating gold mines in western Africa situated along the prolific Ashanti Gold Belt in Ghana. In 2009, production totaled nearly 410,000 ounces of gold from these two mines.

The company’s goal is to grow its business in Ghana and other selected countries such as the Ivory Coast in western Africa. This is a wise choice and not only because of the richness of the Ashanti gold fields. Western Africa is one the most stable areas in Africa and suitable for business. Ghana is one of the most stable countries, politically and economically, in all of Africa.

Golden Star Resources’ current strategy is to focus on exploration and expansion activities at the two mines – Bogoso/Prestea and Wassa/HBB. Its 2010 exploration budget has been raised to $23 million, which is more than double the budget for 2009. The company is well-funded, so it will have no problem carrying out the exploration program.

Most analysts forecast that Golden Star Resources will have double digit increases in both sales and earnings going out for at least 5 years. Estimates are that gold sales from the company will increase about 16% this year and more than 11% next year. Analysts’ earnings projections are for an increase of 143% this year and 58% next year. Earnings are expected to continue at a 5 year annual compounded growth rate of at least 10%.

Let us hear your thoughts below:

CEL-SCI Corp. (CVM) is “One to Watch”

Thursday, September 30th, 2010

CEL-SCI Corp. is a biopharmaceutical company dedicated to improving the treatment of cancer and other infectious diseases by unleashing the power of the body’s immune system. The company’s flagship product is Multikine, the first immunotherapeutic agent being developed as a standard of care treatment for cancer.

The company’s Multikine has been designated as an orphan drug by the US Food and Drug Administration (FDA) and has recently begun a global Phase III trial in advanced primary head and neck cancer patients. In earlier trials, the drug was shown to kill approximately 50 percent of tumor cells before standard treatments start. Multikine also renders residual cancer cells that survive treatment more susceptible to radiation and chemotherapy.

Multikine has several novel characteristics that will differentiate it from the present generation of cancer vaccines: 1) The drug can be used off-the-shelf, making large-scale manufacturing possible; 2) It offers both active and passive immunity, indicating that no outside antigen is needed; 3) The drug is administered to cancer patients when the immune system is strongest (before surgery, radiation or chemotherapy), which CEL-SCI has found to be the optimal time.

It is believed that Multikine may have the potential to be a billion-dollar blockbuster drug, but the company also has other drugs in the pipeline. CEL-SCI’s other products are currently in various stages of pre-clinical development. CEL-2000 has shown promise as a therapeutic vaccine for rheumatoid arthritis. Initial tests in animals have shown that it may be more effective than Enbrel. CEL-1000, on the other hand, may be particularly suitable for development as a bio-defense agent.

Let us hear your thoughts below:

Security Federal Corp. (SFDL.OB) to Participate in United States Department of the Treasury’s Community Development Capital Initiative

Thursday, September 30th, 2010

Security Federal Corporation, the holding company for Security Federal Bank, announced yesterday that they were approved to participate in United States Department of the Treasury’s (the Treasury) Community Development Capital Initiative (CDCI). The CDCI was established by the Treasury to invest lower cost capital in Community Development Financial Institutions (CDFI). This is to support their efforts to provide credit to small businesses and other qualified customers during this challenging economic period.

Participation in the CDCI will provide Security Federal Corporation with $4.0 million in additional capital, along with the $4.0 million from the sale of additional common stock, and lowers the cost of capital received from the Treasury. The annual dividend rate on the Series A Preferred Stock was 5% and was to have increased to 9% on February 15, 2014. The annual dividend rate on the Series B Preferred Stock will be 2% for the first eight years from the date of issuance and 9% thereafter if still then outstanding.

The Company and Security Federal Bank must maintain eligibility as a community development financial institution (CDFI) under Treasury regulations. If they don’t maintain eligibility as a CDFI, the annual dividend rate on the Series B Preferred Stock will increase to 5% if it is not corrected within 180 days and will further increase to 9% if not corrected after 270 days.

In connection with their participation in the CDCI, the Company exchanged all $18.0 million aggregate liquidation preference amount of their Fixed Rate Cumulative Perpetual Preferred Stock, Series A (“Series A Preferred Stock”), previously sold to the Treasury pursuant to the TARP Capital Purchase Program, for $18.0 million aggregate liquidation amount of the Company’s newly designated Fixed Rate Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”).

The Company also sold 400,000 shares of their common stock at $10.00 per share in a private offering to board members of the Company as a result of a required match, for aggregate gross proceeds of $4.0 million.

They received an additional $4.0 million investment from the Treasury through the sale of an additional $4.0 million aggregate liquidation preference amount of Series B Preferred Stock to the Treasury. The additional $4.0 million investment from the Treasury was contingent upon the completion of the $4.0 million match through a private offering of common stock.

Headquartered in Aiken, South Carolina, Security Federal Bank has 13 full service branch locations in Aiken, Clearwater, Graniteville, Langley, Lexington, North Augusta, Wagener, Columbia and West Columbia, South Carolina and Evans, Georgia. The Bank provides a full range of financial services. This includes trust and investments. Insurance services are provided by the Bank’s wholly owned subsidiary, Security Federal Insurance, Inc.

For more information visit:

Let us hear your thoughts below:

Derycz Scientific, Inc. (DYSC.OB) Reports 70% Revenue Increase for Fiscal Year 2010

Thursday, September 30th, 2010

Derycz Scientific, Inc., a company that deals in getting information and content from publishers to consumers, reported financial and operating results for the fiscal year ending on June 30, 2010 in a conference call on Sept. 28.

The highlights included full year revenues increased 70% to $24.9 million, up from $14.7 million in 2009. Their net loss narrowed from $1.1 million to $307,000. Fiscal 2010 fourth quarter revenues increased 51% to $6.4 million from $4.2 million in the 2009 fourth quarter.

“The past fiscal year was exceptionally rewarding for Derycz Scientific. We grew revenues by 70% while significantly expanding our customer base and publisher agreements, and adding to our technology solutions through new business relationships,” said Peter Derycz, President and CEO of Derycz Scientific. “Among our notable recent accomplishments, our main operating subsidiary signed a multi-year contract as the exclusive provider of reprints and ePrints for the prestigious Journal of the American Medical Association and nine additional specialty journals published by the American Medical Association.

“We achieved our goal of narrowing our loss compared with the prior year, even with our decision to increase our sales and marketing, information technology and administrative teams during the past year. We intend to continue monitoring staffing and make appropriate additions to support further growth.

“We expect another year of significant revenue growth for fiscal 2011,” added Mr. Derycz. “Because our customers are spending cautiously in the current economic environment, we are focusing heavily on customer satisfaction and referrals, new customer acquisition and on new products and services to achieve this growth. We also see the need for aggressive pricing to support growth, which should result in gross margin remaining unchanged or down slightly. Our marketing and advertising expense for the current fiscal year are expected to be in the $500,000 range, representing a modest increase from fiscal 2010. We also expect that our cash resources will be sufficient to sustain current operations for the coming year.”

Revenues from Derycz subsidiary Reprints Desk increased 67%, from $13.2 million in 2009 to $22 million in 2010. Pools Press, another subsidiary, contributed the remaining revenues in both periods. Gross margin decreased from 17% in 2009 to 15% in 2010. Derycz expects the gross margin percentage to remain stable, depending on the relative sales of products with differing margins.

General and administrative expenses were $3.6 million in 2010, versus $3.3 million in 2009; marketing and advertising expenses were $440,000 in 2010, up from $158,000 in 2009. As of the end of the 2010 fiscal year, Derycz had cash and cash equivalents of $1.9 million, unchanged from the end of fiscal year 2009.

A webcast replay of the conference call is available on the Derycz Scientific website

Let us hear your thoughts below:

China Pharmaceuticals, Inc. (CFMID.OB) Issues Reverse Stock Split to Gain Footing for Senior Exchange Listing

Thursday, September 30th, 2010

China Pharmaceuticals Inc., a leading manufacturer and distributor of prescription and over-the-counter pharmaceuticals in China, today announced it has effected a 1-for-3 reverse share split as of September 22, 2010. As such, a temporary “D” has been added to the end of the company’s ticker, CFMI; the letter will be removed 20 days after the share split becomes effective.

The company said it has officially filed necessary amendments to the state of Nevada and FINRA for the reverse share split, which was enacted to better position the company for listing in the public market place.

“Today’s announcement further demonstrates to our shareholders that we are taking steps that we feel are necessary to position the company to attain a senior stock exchange listing,” Guozhu Wang, chairman and CEO of China Pharmaceuticals stated in the press release.

China Pharmaceuticals is headquartered in Shaanxi Province, China. The company currently manufactures 132 pharmaceutical products in 11 dosage forms, including capsules, oral solutions, tablets, granules, syrups, medicinal tease, tinctures and injectable solutions.

The company also markets 111 prescription drugs, which contribute 78 percent of sales.

For the half-year ended June 30, 2010, China Pharmaceutical reported record financial results, posting a 79 percent increase in total revenue at $17.5 million. Net income increased 69 percent to $6.0 million as compared to the comparable six-month period of 2009.

For more information visit

Let us hear your thoughts below:

Shengtai Pharmaceutical, Inc. (SGTI.OB) Reports Fiscal 2010 Financial Results, Returns to Profit

Thursday, September 30th, 2010

Shengtai Pharmaceutical Inc. operates through its wholly owned subsidiary, Shengtai Holding Inc., to manufacture and distribute glucose and starch as pharmaceutical raw materials and other starch and glucose products in China. The company today reported its financial results for the 12 months ended June 30, 2010.

Shengtai Pharmaceutical posted sales revenue for the fiscal year ended June 30, 2010, of $115.9 million, a 58-percent increase over sales revenue for fiscal 2009. The company attributes the increase in sales revenue to an increase in sales volume and selling prices.

Net sales from exports for the fiscal year increased approximately 131 percent over the same period in 2009. Domestic sales for cornstarch and other products for the year increased approximately 55 percent compared with the same period last year. The increase is due to the higher demand for the company’s products and increase in unit sales prices.

Qingtai Liu, CEO of Shengtai Pharmaceutical, said the company is on track to extend its global reach and ramped up production of various products to meet demand.

“We are continuing our global expansion and diversification strategies which are currently benefiting from strong market growth. During this past year we increased our production of pharmaceutical grade glucose products, in particular dextrose monohydrate. Dextrose monohydrate is one of the five most important medical prescriptions in the PRC and one of the most widely used pharmaceutical products for restorative and nutritional purposes. It is used as a raw material in a wide array of pharmaceutical products such as transfusions and intravenous drips. Our cornstarch production capacity has been enhanced to 300,000 tons a year,” Liu stated in the press release.

Costs of goods sold for the year ended June 30, 2010 was $98. 2 million, 49 percent more than the cost of goods reported in the comparable 12-month period of 2009. Gross profit for the year ended June 30, 2010, was $17.6 million, an increase of $10.1 million, or 135 percent, compared with the same period in 2009; gross profit margin for the year ended June 30, 2010, was 15.2 percent, a 5 percent increase for the same period in 2009.

Net profit for fiscal 2010 was $3.1 million, or 0.17 per share, as compared to a net loss of $2.6 million, or $0.14 per share for fiscal 2009.

“Our return to profitability is a combination of our cost controls, diversified product lines and numerous sales initiatives. Our glucose facility allows us to use self-produced cornstarch to produce glucose and to be able to ensure the adequacy and quality of the cornstarch we use. Since cornstarch is produced on our premises, we are able to eliminate costs to ship the cornstarch to our glucose production facility, thus resulting in lower manufacturing costs,” Liu stated.

Liu also said the company is applying new production technology to recycle its waste water and by products, while improving overall production.

“Environment protection and production efficiency are important in our growth,” concluded Liu.

For more information visit

Let us hear your thoughts below:

Applied DNA Sciences Inc. (APDN.OB) Video Chart for Thursday, September 30, 2010

Thursday, September 30th, 2010

The chart for APDN shows that the price per share is consolidating after a nice move, holding $.047 as support. As long as the support holds, it is on watch for another potential move upward.

Please click the following link:

Let us hear your thoughts below:

Uranium Energy Corp. (UEC) Makes Significant Move Forward with Permitting for Goliad ISR Project in South Texas

Thursday, September 30th, 2010

Uranium Energy Corp announced today that its Goliad In-Situ Recovery (ISR) Project in South Texas has made a major advance toward becoming permitted for production. The administrative law judge who presided over a public hearing regarding the Company’s Goliad ISR Project in May of this year issued an initial Proposal for Decision (PFD) yesterday.

The administrative judge recommended findings in favor of the Company on the vast majority of the issues from the hearing. In addition, he recommended that the Texas Commission on Environmental Quality (TCEQ) allow the submission of additional data to address limited remaining issues.

Mid-2009, the TCEQ’s Executive Director issued draft permits that would authorize the Company to install the initial wellfield and commence production at Goliad. During the hearing, the Executive Director re-affirmed its position that the permits should be issued. The hearing addressed questions and comments from the public regarding the Company’s mining plans and permits at Goliad. The administrative judge has now submitted an initial proposed decision to the TCEQ Commissioners, who have the authority and latitude to agree or disagree with his recommendations.

Harry Anthony, Chief Operating Officer, commented, “We look forward to submitting any additional data that is needed and to completing this phase of the permitting process. The Company is confident that the permits will be approved at the end of this process.”

The additional limited information for the administrative judge involves a 24-hour pump test at the Goliad project. The Company said its pleased to have this test performed and to provide the data. According to today’s press release, the viability of operations at Production Area One or any future Production Areas is not affected by the results of the test.

Let us hear your thoughts: Uranium Energy Message Board

eDoorways International Corp. (EDWY.PK) Builds Platform with Focus on Personalization and Collaboration

Thursday, September 30th, 2010

Regardless of their age or background, people have one thing in common when it comes to the internet, they want a personal experience. Gary Kimmons, president of eDoorways International Corporation, stated, “There has been a lot of talk recently about the emergence of a Web 3.0 which is the future of the internet. The problem is, people don’t understand what Web 3.0 is, but, they’re in for a real treat.”

eDoorways is a web-based consumer problem solving gateway, lifestyle information source, and online business-to-consumer marketplace designed to save consumers valuable time and money by uniting them with the global consumer community, retailers, and manufacturers in an effective new way. Put simply, eDoorways is a collaborative venue that connects people with questions to experts with answers, solutions, and recommendations.

“This is only the beginning of the Web 3.0 experience. Our platform will allow users to customize their internet and connect in a new way, not yet seen on the internet,” Kimmons explained. Personalizing the web for the hundreds of millions of active users across the world is a true revolution, creating huge room for profitability. “We are excited to be leading the way in this multi-billion dollar industry as well as into the future of the internet,” Kimmons continued. “We will continue to work closely with some of the greatest engineering minds to continually improve the Web 3.0 experience.”

Let us hear your thoughts: eDOORWAYS Corp. Message Board

National Automation Services, Inc. (NASV.PK) Announces Expansion into California

Thursday, September 30th, 2010

National Automation Services, Inc. (“NAS”) announced this morning that it is expanding into California. The company also told investors that its acquisition growth strategy remains on track.

Bob Chance, CEO of National Automation Services, stated, “Our focus on the California market for automation and controls projects over the past year has justified our expansion in the area. We are currently working with two Equipment Manufacturers designing and building their control systems. Also, we have been awarded, completed, and have pending contracts for public utilities in the Los Angeles area. Although we have opened an office in California, we are currently looking for excellent acquisition opportunities that meet our requirements.

“Talks are underway with other firms to be acquired throughout the U.S. and our desire to move forward on becoming a National producer of automation and controls solutions to Municipalities and Industry is unfolding very quickly and is our primary focus going forward,” he concluded.

Let us hear your thoughts: National Automation Services, Inc. Message Board

Flagstar Bancorp Inc. (FBC) Video Chart for Wednesday, September 29, 2010

Wednesday, September 29th, 2010

FBC is a NYSE financial play that is struggling along with many other companies in the financial sector. It is still on radar as it is once again tries to form a base and hold support.

Please click the following link:

Let us hear your thoughts below:

Arkanova Energy Corp. (AKVA) Issues Operational Update

Wednesday, September 29th, 2010

Arkanova Energy Corp. reported on the status of the company’s drilling activities at its oil and gas prospect in Montana.

Arkanova Energy Corporation said that the company is currently drilling the horizontal portion of the Tribal-Max 1-2817 well. The well is located in Glacier County, Montana, at the Two Medicine Cut Bank Sand Unit.

The Tribal-Max 1-2817 was drilled to a vertical depth of 3,579 feet and has now reaches a total measured depth of 5,238 feet. Arkanova Energy Corporation is targeting the Lower Cut Bank Sand formation at the Two Medicine Cut Bank Sand Unit.

Arkanova Energy Corporation conducts its drilling activities in Montana through Provident Energy Associates of Montana, LLC. The company has approximately 9,900 net acres under lease here that is prospective for oil and natural gas.

Arkanova Energy Corporation has twenty-two active producing wells at the Two Medicine Cut Bank Sand Unit. The company has another thirty wells awaiting recompletion.

Arkanova Energy Corporation is also targeting other formations during the drilling of the Tribal-Max 1-2817, including the Exshaw Shale, Three Forks and Lodgepole formations. Arkanova Energy Corporation also has properties in Arkansas where the company has 43,500 gross acres under lease and Colorado, where it has 1,320 gross acres under lease.

For more information on the company, go to

Let us hear your thoughts below:

Payment Data Systems, Inc. (PYDS.OB) Moves to Fully Acquire Assets of Electronic Recovery Systems LLC

Wednesday, September 29th, 2010

Payment Data Systems, – the payment solutions provider bridging the gap for merchants, billers, banks, etc. via a sophisticated yet intuitive array of world-class payment acceptance products, reported signing of a Letter of Intent (LOI) to acquire 100% of Electronic Recovery Systems LLC’s (ERS) assets today.

Chairman and CEO of PYDS, Michael Long, cited the leadership status of ERS in the ACH (Automated Clearing House) return processing market and its minimal personnel as shining indicators that this acquisition spells success for the Company and its shareholders, given a market niche that generates $1.2M in annual revenues and $300k in annualized EBITDA.

Long praised the iterative process of parallel competencies between the two firms, and a subsequent minimalism in requisite sales forces, both of which will result in a highly efficient and tight-knit machine capable of readily obtaining the projected increase in EBITDA to more than $800k annually post-acquisition.

Long also detailed the robust position of ERS in the ACH processing market, via solutions ranging from return check services and consolidated returns to electronic check conversion, check guarantee and verification.

Furthermore, ERS’s dominant position in the sector is underwritten by a bevy of Fortune 1000 merchant and recurring biller clientele, representing a massive front which opens up the entire field for the PYDS family of companies to win substantial revenue streams.

The ability to cross-sell and find acquisitions for PYDS will dovetail nicely into the emergence of an overarching unified payments processing facility which can offer merchants a highly sought after, one-stop-shop for all of their payments service requirements.

Long argued that the accretive earnings and parallel impetus which PYDS’s sales and marketing strategies engender make this acquisition an ideal stratagem for rendering the Company “immediately profitable” via generation of some $200k per quarter in cash.

The LOI is contingent upon due diligence from both parties, valid financing, and customary closing documents with standard terms/conditions; additional specific terms of the LOI have not yet been disclosed to the public.

Let us hear your thoughts below:

Points International Ltd. (PTSEF.OB) Expands Continental Airlines Partnership, Allowing OnePass® Members New Exchange and Purchase Options

Wednesday, September 29th, 2010

Points International, – the owner and operator of the world’s top loyalty reward program management site, – where consumers have unprecedented control over the management of points from over 25 leading rewards programs, reported today expansion of service to include Continental Airlines’ OnePass® frequent flyer program.

Continental is the fifth largest airline on the planet, and the expansion of the relationship is very good news for, which is increasingly carving out an ever more dominant foothold in the sector as the undisputed master of points/mileage management solutions.

Members can now freely exchange miles into other loyalty accounts or redeem points at leading retailers or for flights/services, significantly expanding the mutually beneficial relationship between Continental and, which previously only allowed exchanges between users.

This new capacity harnesses the powerful framework allowing OnePass members the ability to not only openly exchange points/miles but also to make purchases via gift cards at hundreds of such recognized major retailers as Best Buy® and Target.

CEO of, Rob MacLean, noted how huge the over 35M-member Continental OnePass is within the airline industry and described the benefits of this expansion of the relationship between the two companies as twofold, in that it allows Continental’s members to get their hands on even more OnePass miles via leveraging of other programs while boosting the overall value of the program.

Senior VP of Marketing Programs and Distribution for Continental, Mark Bergsrud, explained a little further, pointing out how the customer satisfaction of OnePass members would be massively increased via this expansion of the partnership, which he characterized as “a natural next step” for Continental.

Also available to OnePass members will be the powerful mileage balance tracking capabilities of the platform, allowing users the ability to quickly appraise mileage over two dozen other programs like American Airlines AAdvantage®, Alaska Airlines Mileage Plan, Delta SkyMiles® and US Airways Dividend Miles.

Let us hear your thoughts below:

ProUroCare Medical, Inc. (PUMD.OB) Announces $3 Million Financing Agreement

Wednesday, September 29th, 2010

ProUroCare Medical Inc. is a company which develops and provides innovative medical imaging products. The company’s current focus is its proprietary ProUroScan prostate imaging system which is used to visualize and document abnormalities of the prostate gland in men.

The company announced on September 28, 2010 the signing of an agreement for $3.125 million in equity financing with Seaside 88 LP. The funding will be provided in four tranches. The first closing, completed upon the signing of the agreement, provides $875,000 at a selling price of $0.625 per share. Subsequent closings are scheduled to provide $750,000 within 30 days following FDA clearance of the ProUroScan system, and $1.5 million provided in five subsequent closings of $300,000 in 30-day increments.

The proceeds of the financing will be used to expand the company’s product portfolio and to support scale-up activities associated with final preparation, manufacturing and eventual marketing of the ProUroScan prostate imaging system, following FDA clearance. This funding brings the total amount of money raised by ProUroCare since January 2007 to $13.9 million.

There are several activities required to prepare a product for marketing following FDA clearance. Needless to say, this funding will enable the company to do so. It will also allow ProUroCare Medical to move other key programs forward during the ongoing FDA review period. For further information on the company and its ProUroScan system, please visit its website at

Let us hear your thoughts below:

Micro Identification Technologies, Inc. (MMTC.OB) Receives Additional Funding

Wednesday, September 29th, 2010

Micro Identification Technologies Inc., creator of the MIT 1000, the world’s first and only non-biological automated system for identifying bacteria, announced today that it has entered into a securities purchase agreement with a privately held New York investment banking firm.

The terms of the agreement call for an 8% note set to mature on May 18, 2011. In addition, the note is convertible into common shares, in total or in part, prior to the maturity date, commencing 180 days following the date of the note. The company will be hosting a Webinar 9/29/10 at 4:00 PM EDT (1:00 PDT) to provide information regarding its current business plans.

This funding is in addition to the recent announcement of an equity financing commitment from Dutchess Capital. MIT expects to receive more funding from this or other firms in upcoming months as part of an effort to accelerate a planned production launch and marketing campaign later this year. MIT’s Chairman and CEO, Michael Brennan, stated, “This funding will significantly help MIT achieve its near term goals and, together with expected future funding, will enable MIT to exceed its short and medium term plans.”

The MIT 1000 effectively revolutionizes bacterial identification by replacing traditional requirements for biological processing and subjective evaluation with a quick and totally automated process that produces results in minutes, versus days. Instead of using complex chemical or biological agents, fluorescent tags, gas chromatography, or DNA analysis, the MIT 1000 uses the unique patterns generated by reflected laser light from a small sample of the bacteria. The patterns are analyzed by the company’s software to provide a quick and accurate identification, and at a far lower cost.

For more information, visit

Let us hear your thoughts: Micro Identification Technologies Inc. Message Board

Simulated Environment Concepts, Inc. (SMEV.PK) Goes Irish

Wednesday, September 29th, 2010

As well as being the Director of the National Training Centre (NTC), Ireland’s leading education campus for health, fitness, and bodywork therapy, John Sharkey is the founder and developer of European Neuromuscular Therapy. He’s an experienced Exercise Physiologist and Neuromuscular Therapist, and works closely with the Irish Olympic Team. So when Simulated Environment Concepts Inc. first introduced their revolutionary SpaCapsule personal health and relaxation system to Ireland, John was one of the top professionals they knew they had to impress.

John’s professional evaluation was unequivocal: “This is a great unit, there’s no doubt about it.” Even to a trained therapist, the multi-dimensional features of SpaCapsule are impossible to ignore. The system is a self-contained personal environment capsule, combining computer controlled dry hydro-message with visual, sound, and even aroma therapy, to provide an incomparable physical and mental effect. Created by doctors, SpaCapsule is, among other things, a perfect augment to traditional therapy. As John puts it, “Although you can’t substitute for a good qualified therapist, the SpaCapsule is an adjunct to what they can offer their clients”. The system can even pump oxygen into the capsule to boost energy levels.

Ireland is just the latest SpaCapsule conquest. The futuristic system has become popular with health, beauty, and fitness practitioners around the world. There’s no need for a client to remove their clothes since they are kept dry at all times by a waterproof membrane separating them from the rhythmically pulsating water jets. There’s even a remote control to hold the jets in a given position at any time, giving the user total control.

SpaCapsule is now showing up in health centers, spas, and doctor’s offices, as well as private homes. SEC has even negotiated an agreement with distribution company I. SEPTA Co., Ltd, for the distribution of units throughout the Middle East. In many ways, SpaCapsule is a product that sells itself, providing an experience simply not available any place else.

For more information, see the company websites at and

Let us hear your thoughts: Simulated Environment Concepts Inc. Message Board

China North East Petroleum Holdings Ltd. (NEP) Reaches Agreement to Drill Wells in Inner Mongolia

Wednesday, September 29th, 2010

China North East Petroleum Holdings Ltd. announced that the company has reached an agreement to provide oil drilling and other services at an oil field in Inner Mongolia.

China North East Petroleum Holdings Ltd. said that Song Yuan Tiancheng Drilling Engineering Co. Ltd., which is the company’s oil services subsidiary, agreed to drill one hundred wells for Beijing Junlun Runzhong Technology Co. Ltd.

China North East Petroleum Holdings Ltd. purchased Song Yuan Tiancheng Drilling Engineering Co. Ltd. in 2009, and has entered into six drilling agreements with various parties since then. The company has drilled a total of 142 wells during the first eight months of 2010.

China North East Petroleum Holdings Ltd. said that the drilling program would begin immediately and last approximately twelve months. The company will utilize two rigs at the field in Inner Mongolia.

The value of the drilling contract was not specified by China North East Petroleum Holdings Ltd., as Beijing Junlun Runzhong Technology Co. Ltd. is required to pay for each well based on the depth of the drilling.

China North East Petroleum Holdings Ltd. also owns interests in four oil and gas fields in Northern China and has a contract to sell its oil and gas output to PetroChina.

For more information on the company, go to

Let us hear your thoughts below: